PJ-008200 Measurements on healthy subjects to design a nociception index - Measurements to design a nociception index

Philips Patient Monitoring (Philips Medizin-Systeme Böblingen GmbH)0 个研究点目标入组 40 人开始时间: 待定最近更新: 2024年6月11日

适应症

试验速览

暂无简介。

•1) Pregnancy (pregnancy test before start protocol, if female, with the
•exception of post menstrual women)
•2) Smoking
•3) Alcohol abuse
•4) Medication that influeunces the central or peripheral nervous system, or the
•cardiovascular system
•5) Drug use (drug test before start protocol)
•6) Raynaud's disease (poor blood circulation)
•7) Scleroderma, Dupuytren*s Contracture, or other Rheumatology issues
•8) Depression and/or anxiety (the Hospital Anxiety and Depression Scale (HADS)
•questionnaire is given before the start of the protocol. Subjects with a score
•greater than or equal to 11 are excluded)
•9) Food eaten in the 6 hours before the test
•10) Fluid intake within less than 2 hours of the planned start of
•experimentation
•11) Use of caffeinated beverages in the 12 hours before the test
•12) Use of caffeinated food (e.g. chocolate) in the 6 hours before the test
•COVID-19 additional
•13) Currently displaying COVID-19-related symptoms, namely a fever, cough
•and/or difficulty breathing
•14) Having been positively tested as infected with COVID-19 in the past 14 days
•15) Travelled to or from high risk COVID-19 areas in the past 14 days
•16) Been in contact with a (suspected) COVID-infected person in the past 14

发起方

Philips Patient Monitoring (Philips Medizin-Systeme Böblingen GmbH)